Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by Metalsguy1on Nov 25, 2021 6:05am
435 Views
Post# 34164355

2021 Lump of coal...

2021 Lump of coal...
Well here it is, the end of November and the end of year rapidly approaching and what is there to show for it? January. A happy accident with the Witkowski presentation that sent the share price streaking to new new highs. What might have happened? The company could have ridden a momentum wave, focused their energy on accelerating the study and advancing at least the thyroid indication and generating more substantive news to support a mildly dilutive financing at $2 plus. What happened? A highly dilutive financing wherein Doug cow..I mean Lowe helped swindle existing shareholders out of hard earned equity and left such a taint on the stock that most of the year the stock has languished. News? What news? As has been typical over the years, the rumor mill spent a good part of the year churning out speculation that a deal was imminent. The only thing imminent is a world wide shift into an engaging holiday season fueled by a pandemic exhausted world that wil likely leave any deals in progress to collect dust on the conference room table. And the 7th patient is out there somewhere like the great white whale in a study we were led to believe would be concluded in less than two years. Even allowing for pandemic years 4 years is unreasonable. What has management excelled at? Placating a sufficient number of investors to scrape by with an approval to further dilute the stock with an egregious share grab to feather the nest. Dazzling noobs with grandiose visions unsubstantiated by any evidence of real value driving progress. The odds of anything happening before year end on any substantive front are not non-existent but the odds for an extinction level asteroid striking earth are higher. My prediction is a lump of coal in everyone's stocking this December. How is that for an assessment and prediction Fraulein?
<< Previous
Bullboard Posts
Next >>